Tauriga Sciences, Inc. CEO to Deliver Presentation on Cannabis Investments at the NY TradersEXPO on March 9th at 9:00AM EST
March 02 2020 - 11:00AM
InvestorsHub NewsWire
Tauriga Sciences, Inc. CEO to
Deliver Presentation on Cannabis Investments at the NY TradersEXPO
on March 9th at 9:00AM EST
The
Presentation is Titled: “Differentiating from Competitors and
Establishing Barriers to Entry in the Nascent CBD Edibles
Sector”
NEW YORK, NY -- March 2, 2020 -- InvestorsHub NewsWire --
Tauriga Sciences, Inc. (OTCQB: TAUG)
(“Tauriga” or the “Company”), a revenue generating Company that
operates through the development, distribution, and licensing of
proprietary products as well as the evaluation of potential
acquisition opportunities and equity investments, today announced
that its Chief Executive Officer (“CEO”), Mr. Seth M.
Shaw, will deliver the presentation on Cannabis Investments at the
NY TradersEXPO (“MoneyShow”) on March 9, 2020 at 9:00am
EST. This presentation will be half an hour long and
take place at the New York Marriot Hotel – at the Brooklyn
Bridge. The Company is also operating a main floor
Exhibitor Booth (# 211) at this NY TradersEXPO Tradeshow and
expects to interact with a number of potential new
investors.
This presentation, titled: “Differentiating from Competitors and
Establishing Barriers to Entry in the Nascent CBD Edibles Sector,”
is expected to be attended by several hundred accredited individual
and institutional investors and provides the Company with an
opportunity to expand both its investor and market
awareness.
Link to Presentation: https://conferences.moneyshow.com/tradersexpo-new-york/speakers/7008e3674d354293a191431396539b50/seth-shaw/?scode=049647
In other news, the Company continues to progress in its efforts
to develop a Pharmaceutical grade version of Tauri-Gum™ and expects
to update shareholders in the near future. This proposed
Pharmaceutical product is focused on Nausea Regulation,
specifically pertaining to patients subjected to ongoing
chemotherapy treatment. During January 2020, the Company
retained the law firm of Lowenstein Sandler LLP to assist it in
these efforts.
ABOUT TAURIGA SCIENCES INC.
Tauriga Sciences, Inc. (TAUG)
is a revenue generating Company that operates through the
development, distribution, and licensing of proprietary products as
well as the evaluation of potential acquisition opportunities. One
such opportunity on which the Company has acted, involves the
Company having entered into the cannabidiol (or “CBD”) infused
chewing gum product business, as more fully described above and in
prior press releases. This CBD infused chewing gum product
has been branded under the following name:
Tauri-Gum™. The Company is currently in production of
three distinct flavors of Tauri-Gum™: MINT, BLOOD ORANGE, and
POMEGRANATE. On December 6, 2019 the Company announced
that it completed the initial production run (thereby expanding its
existing product lines) with the introduction of a 25mg Vegan CBD
Isolate Infused vegan gummy (“gum drop”), branded under the name:
Tauri-Gummies™. Further, the Company continues to
identify and evaluate additional potential opportunities to
generate revenue, as well as shareholder value, and leverage its
resources and expertise to build a diversified and sustainable
business model. Please visit our corporate website
at www.tauriga.com.
The Company has also announced the development of a Cannabigerol
(“CBG”) Isolate infused version of Tauri-Gum™. The
flavor that has been selected is Starfruit/Peach and each piece of
gum will contain 10mg of CBG Isolate / Each blister pack will
contain 80mg of CBG Isolate. The Company expects to
commence production during its 4thFiscal Quarter of 2020
(January 1, 2020 – March 31, 2020).
In addition, on March 11, 2019, the Company announced the official
launch of its E-Commerce site - as part of its Tauri-Gum™
commercialization strategy. This site can be accessed by
visiting the following URL address: www.taurigum.com
The Company has established corporate offices in both New York City
(USA) and Barcelona (Spain).
DISCLAIMER -- Forward-Looking Statements
This press release contains certain “forward-looking statements” as
defined by the Private Securities Litigation Reform Act of 1995
which represent management’s beliefs and assumptions concerning
future events. These forward-looking statements are often indicated
by using words such as “may,” “will,” “expects,” “anticipates,”
believes, “hopes,” “believes,” or plans, and may include statements
regarding corporate objectives as well as the attainment of certain
corporate goals and milestones. Forward-looking statements are
based on present circumstances and on management’s present beliefs
with respect to events that have not occurred, that may not occur,
or that may occur with different consequences or timing than those
now assumed or anticipated. Actual results may differ materially
from those expressed in forward looking statements due
to known and unknown risks and uncertainties, such as are not
guarantees of general economic and business conditions, the ability
to successfully develop and market products, consumer and business
consumption habits, the ability to consummate successful
acquisition and licensing transactions, fluctuations in exchange
rates, and other factors over which Tauriga has little or no
control. Many of these risks and uncertainties are discussed in
greater detail in the “Risk Factors” section of Tauriga’s Form 10-K
and other filings made from time to time with the Securities and
Exchange Commission. Such forward-looking statements are made only
as of the date of this release, and Tauriga assumes no obligation
to update forward-looking statements to reflect subsequent events
or circumstances. You should not place undue reliance on these
forward-looking statements.
CONTACT
INFORMATION
Tauriga Sciences, Inc.
555 Madison Avenue, 5th Floor
New York, NY 10022
Chief Executive Officer
Mr. Seth M. Shaw
Email: sshaw@tauriga.com
cell # (917) 796 9926
Corp. Website: www.tauriga.com
E-Commerce
Website: www.taurigum.com
Tauriga Sciences (CE) (USOTC:TAUG)
Historical Stock Chart
From Mar 2024 to Apr 2024
Tauriga Sciences (CE) (USOTC:TAUG)
Historical Stock Chart
From Apr 2023 to Apr 2024